Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 3 Cerebral palsy (CP) subtypes and impairments among children with and without developmental anomalies (DAs)

From: Developmental anomalies and associated impairments in Saudi children with cerebral palsy: a registry-based, multicenter study

Variables

CP with skeleton DAs (n = 101)

CP with nervous DAs (n = 56)

CP with other DAs (n = 31)

CP without DAs (n = 491)

P1

P2

P3

P4

P5

Clinical subtypes

 Spastic unilateral

21 (20.8%)

14 (25.0%)

16 (51.6%)

69 (14.0%)

< 0.001*

0.02*

0.01*

< 0.001*

0.002*

 Spastic bilateral

80 (79.2%)

36 (64.3%)

15 (48.4%)

381 (77.6%)

     

 Dyskinetic

0 (0.0%)

6 (10.7%)

0 (0.0%)

22 (4.5%)

     

 Ataxic

0 (0.0%)

0 (0.0%)

0 (0.0%)

19 (3.9%)

     

Impairments

 

 Intellectual disability

         

 None

76 (75.2%)

22 (39.4%)

18 (58.1%)

278 (56.7%)

< 0.001*

0.001*

0.0004*

0.98

< 0.001*

 Mild-moderate

14 (13.9%)

16 (28.5%)

9 (29.0%)

150 (30.5%)

     

 Severe-profound

11 (10.9%)

18 (32.1%)

4 (12.9%)

63 (12.8%)

     

Motor impairment

 Mild

62 (61.4%)

31 (55.3%)

19 (61.3%)

422 (85.9%)

< 0.001*

< 0.001*

< 0.001*

0.001*

0.65

 Moderate

10 (9.9%)

8 (14.3%)

4 (12.9%)

20 (4.1%)

     

 Severe

29 (28.7%)

17 (30.4%)

8 (25.8%)

49 (10.0%)

     

Speech impairment

 None

61 (60.5%)

29 (51.8%)

18 (58.1%)

350 (71.3%)

0.001*

0.007*

0.009*

0.01*

0.33

 Mild-moderate

23 (22.7%)

12 (21.4%)

9 (29.0%)

55 (11.2%)

     

 Severe-no speech

17 (16.8%)

15 (26.8%)

4 (12.9%)

86 (17.5%)

     

Visual impairment

 None

85 (84.2%)

21 (37.5%)

23 (74.2%)

214 (43.6%)

< 0.001*

< 0.001*

< 0.001*

< 0.001*

< 0.001*

 Mild-moderate

12 (11.8%)

29 (51.8%)

5 (16.1%)

273 (55.6%)

     

 Severe-blind

4 (4.0%)

6 (10.7%)

3 (9.7%)

4 (0.8%)

     

Hearing impairment

 None

86 (85.1%)

34 (60.6%)

21 (67.7%)

393 (80.1%)

< 0.001*

0.2

< 0.001*

< 0.001*

0.002*

 Mild-moderate

13 (12.9%)

17 (30.4%)

7 (22.6%)

94 (19.1%)

     

 Severe-profound

2 (2.0%)

5 (9.0%)

3 (9.7%)

4 (0.8%)

     

Seizures

 No

77 (76.2%)

29 (51.8%)

28 (90.3%)

349 (71.1%)

0.0007*

0.29

0.003*

0.02*

0.002*

 Yes

24 (23.8%)

27 (48.2%)

3 (9.7%)

142 (28.9%)

     
  1. P1 comparison between skeleton DA group, nervous DA group, and no DA group; P2 comparison between skeleton DA group and no DA group; P3 comparison between nervous DA group and no DA group; P4 comparison between other DA group and no DA group; P5 comparison between skeleton DA group and nervous DA group
  2. *Significant p value
Back to article page